Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) and Custom Truck One Source (NYSE:CTOS – Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, risk, dividends and earnings.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Capstone Therapeutics and Custom Truck One Source, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
| Custom Truck One Source | 2 | 1 | 4 | 1 | 2.50 |
Custom Truck One Source has a consensus target price of $11.21, indicating a potential upside of 6.49%. Given Custom Truck One Source’s stronger consensus rating and higher possible upside, analysts plainly believe Custom Truck One Source is more favorable than Capstone Therapeutics.
Insider & Institutional Ownership
Valuation and Earnings
This table compares Capstone Therapeutics and Custom Truck One Source”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Capstone Therapeutics | $48.11 million | 0.10 | -$21.23 million | ($3.37) | -0.09 |
| Custom Truck One Source | $1.94 billion | 1.23 | -$31.05 million | $0.09 | 117.01 |
Capstone Therapeutics has higher earnings, but lower revenue than Custom Truck One Source. Capstone Therapeutics is trading at a lower price-to-earnings ratio than Custom Truck One Source, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Capstone Therapeutics has a beta of -1.52, indicating that its share price is 252% less volatile than the S&P 500. Comparatively, Custom Truck One Source has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.
Profitability
This table compares Capstone Therapeutics and Custom Truck One Source’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Capstone Therapeutics | -41.26% | -114.15% | -39.74% |
| Custom Truck One Source | 1.05% | 2.66% | 0.61% |
Summary
Custom Truck One Source beats Capstone Therapeutics on 13 of the 15 factors compared between the two stocks.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
About Custom Truck One Source
Custom Truck One Source, Inc. provides specialty equipment rental and sale services to the electric utility transmission and distribution, telecommunications, rail, forestry, waste management, and other infrastructure-related industries in the United States and Canada. The company operates through three segments: Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). The ERS segment owns new and used specialty equipment, including truck-mounted aerial lifts, cranes, service trucks, dump trucks, trailers, digger derricks, and other machinery and equipment. The TES segment offers new equipment for sale to be used for end-markets, which can be modified to meet customers specific needs. The APS segment provides truck and equipment maintenance and repair services; and rents and sells specialized tools, including stringing blocks, insulated hot stick, and rigging equipment, as well as sale of specialized aftermarket parts. The company was formerly known as Nesco Holdings, Inc. and changed its name to Custom Truck One Source, Inc. in April 2021. Custom Truck One Source, Inc. was founded in 1988 and is headquartered in Kansas City, Missouri.
Receive News & Ratings for Capstone Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capstone Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
